FINANCIALS

ALNY Alnylam Pharmaceuticals Inc 1178670

Income Statement
Revenue	alny-20240930	500,919,000
Net Income	alny-20240930	-111,570,000
Profit Margin		-22.27%

Balance Sheet
Current Assets	3,355,424,000
Assets	4,205,039,000
Current Liabilities	1,220,663,000
Liabilities	4,172,685,000
Equity	32,354,000
Shares Out	128,381,000

Cash Flow Statement
Operating Cash Flow	86,350,000
Investing Cash Flow	-63,930,000

Market Analysis
Market Cap	37,449,845,386
Price	246.27
BVPS	0.25
PB	980.32
EPS	-0.63
PS	18.69
FCF	22,420,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ALNY documents filed with the SEC.

ALNY Filings Clear

View A List of Tickers